Ishihara Chemical (4462) · InitiativeRestated
Development and Market Launch of Copper Nano Antimicrobial and Antiviral Products
First written in FY2023. 1 of 2 entries say "Restated". Latest entry: FY2025.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Development and Rollout of Antibacterial and Antiviral ProductsA theme 24 companies write about · 1 as a headwind · 26 as a tailwind
4 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 24 companies compared. The sentences above are computed from all 24.Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「The company is currently developing a specially formulated resin masterbatch with a high loading of copper nanoparticles and evaluating it jointly with customers.」
The company has reiterated its policy of jointly evaluating with customers and advancing the market launch of an antibacterial and antiviral resin masterbatch using copper nanoparticles. - FY2023First statedAnnual report
「The company is currently developing a specially formulated resin masterbatch with a high loading of copper nanoparticles and evaluating it jointly with customers. Because it delivers high efficacy even against highly resistant bacteria and viruses through a simple formulation that only needs to be mixed during resin molding, the company is proceeding with its market launch with the aim of contributing to safety and security in society going forward.」
The company has described a new research and development theme involving the use of copper nanoparticles, a raw material for conductive copper-nanoparticle ink, to jointly evaluate with customers an antibacterial and antiviral resin masterbatch and advance its market launch.